ET-1 induced downregulation of MRP2 via miRNA 133a-a marker for tubular nephrotoxicity?

American Journal of Nephrology

Volumn 41, Issue 3, 2015, Pages 191-199

  Loeser, Heike ^a   Von Brandenstein, Melanie ^a   Herschung, Angela ^a   Schlosser, Monika ^a   Büttner, Reinhard ^a   Fries, Jochen W U ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Endothelin 1; microRNA 133a; MRP2; Proteinuric human disease; RPTEC

Indexed keywords

ENDOTHELIN 1; MICRORNA; MICRORNA 133A; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MESSENGER RNA; MIRN133 MICRORNA, HUMAN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; KIDNEY PROXIMAL TUBULE; MALE; MIDDLE AGED; MOUSE; NEPHROTOXICITY; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TUBULAR NEPHROTOXICITY; URINALYSIS; WESTERN BLOTTING; YOUNG ADULT; ANIMAL; BIOPSY; CELL CULTURE TECHNIQUE; CYTOLOGY; FEMALE; GENETICS; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY;

ADOLESCENT; ADULT; ANIMALS; BIOMARKERS; BIOPSY; CELL CULTURE TECHNIQUES; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; DRUG RESISTANCE, MULTIPLE; ENDOTHELIN-1; FEMALE; HUMANS; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICRORNAS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RNA, MESSENGER; YOUNG ADULT;

EID: 84927943653     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000381272     Document Type: Article

References (37)

1. Thomas H, Coley HM: Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control 2003; 10: 159-165.
2. Sekine T, Miyazaki H, Endou H: Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 2006; 290:F251-F261.
3. Debenham PG, Kartner N, Siminovitch L, Riordan JR, Ling V: DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Mol Cell Biol 1982; 2: 881-889.
4. Juliano RL, Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-162.
5. Borst P, Evers R, Kool M, Wijnholds J: A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92: 1295-1302.
6. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P: Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 1997; 57: 3537-3547.
7. Tan B, Piwnica-Worms D, Ratner L: Multidrug resistance transporters and modulation. Curr Opin Oncol 2000; 12: 450-458.
8. Kockx M, Guo DL, Traini M, Gaus K, Kay J, Wimmer-Kleikamp S, Rentero C, Burnett JR, Le Goff W, Van Eck M, Stow JL, Jessup W, Kritharides L: Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway. J Biol Chem 2009; 284: 24144-24154.
9. Ong AC, Jowett TP, Firth JD, Burton S, Karet FE, Fine LG: An endothelin-1 mediated autocrine growth loop involved in human renal tubular regeneration. Kidney Int 1995; 48: 390-401.
10. Miller DS, Masereeuw R, Karnaky KJ Jr: Regulation of MRP2-mediated transport in shark rectal salt gland tubules. Am J Physiol Regul Integr Comp Physiol 2002; 282:R774-R781.
11. Masereeuw R, Terlouw SA, van Aubel RA, Russel FG, Miller DS: Endothelin B receptormediated regulation of ATP-driven drug secretion in renal proximal tubule. Mol Pharmacol 2000; 57: 59-67.
12. von Brandenstein M, Richter C, Fries JW: microRNAs: small but amazing, and their association with endothelin. Life Sci 2012; 91: 475-489.
13. Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, Seki N, Nakagawa M: The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer 2012; 48: 827-836.
14. Wen X, Buckley B, McCandlish E, Goedken MJ, Syed S, Pelis R, Manautou JE, Aleksunes LM: Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice. Am J Pathol 2014; 184: 1299-1308.
15. Gerstung M, Roth T, Dienes HP, Licht C, Fries JW: Endothelin-1 induces NF-kappaB via two independent pathways in human renal tubular epithelial cells. Am J Nephrol 2007; 27: 294-300.
16. Fries JW, Roth T, Dienes HP, Weber M, Odenthal M: A novel evaluation method for paraffinized human renal biopsies using quantitative analysis of microdissected glomeruli and VCAM-1 as marker of inflammatory mesangial cell activation. Nephrol Dial Transplant 2003; 18: 710-716.
17. von Brandenstein M, Depping R, Schäfer E, Dienes HP, Fries JW: Protein kinase C ? regulates nuclear pri-microRNA 15a release as part of endothelin signaling. Biochim Biophys Acta 2011; 1813: 1793-1802.
18. Ikeda K, Monden T, Kanoh T, Tsujie M, Izawa H, Haba A, Ohnishi T, Sekimoto M, Tomita N, Shiozaki H, Monden M: Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J Histochem Cytochem 1998; 46: 397-403.
19. Abbate M, Zoja C, Remuzzi G: How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006; 17: 2974-2984.
20. Kohan DE: Endothelins in the normal and diseased kidney. Am J Kidney Dis 1997; 29: 2-26.
21. Brunner HR: ACE inhibitors in renal disease. Kidney Int 1992; 42: 463-479.
22. Savage S, Schrier RW: Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors. Adv Intern Med 1992; 37: 85-101.
23. Leier I, Hummel-Eisenbeiss J, Cui Y, Keppler D: ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int 2000; 57: 1636-1642.
24. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993; 43: 354-358.
25. Fukui M, Nakamura T, Ebihara I, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H: Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 1993; 122: 149-156.
26. Yoshimura A, Iwasaki S, Inui K, Ideura T, Koshikawa S, Yanagisawa M, Masaki T: Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat. Kidney Int 1995; 48: 1290-1297.
27. Licht C, Laghmani K, Yanagisawa M, Preisig PA, Alpern RJ: An autocrine role for endothelin-1 in the regulation of proximal tubule NHE3. Kidney Int 2004; 65: 1320-1326.
28. Tan RJ, Zhou L, Zhou D, Lin L, Liu Y: Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy. PLoS One 2013; 8:e79963.
29. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, Watanabe S, Baba O, Kojima Y, Shizuta S, Imai M, Tamura T, Kita T, Kimura T: Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 2011; 4: 446-454.
30. Zhang J, Guo X, Chang DY, Rosen DG, Mercado-Uribe I, Liu J: CD133 expression associated with poor prognosis in ovarian cancer. Mod Pathol 2012; 25: 456-464.
31. de Melo Maia B, Lavorato-Rocha AM, Rodrigues LS, Coutinho-Camillo CM, Baiocchi G, Stiepcich MM, Puga R, de A Lima L, Soares FA, Rocha RM: MicroRNA portraits in human vulvar carcinoma. Cancer Prev Res (Phila) 2013; 6: 1231-1241.
32. Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS: Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res 2013; 19: 4477-4487.
33. Vlachojannis JG, Tsakas S, Petropoulou C, Goumenos DS, Alexandri S: Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria. Clin Nephrol 2002; 58: 337-343.
34. Zoja C, Liu XH, Abbate M, Corna D, Schiffrin EL, Remuzzi G, Benigni A: Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy. Exp Nephrol 1998; 6: 121-131.
35. Jemnitz K, Heredi-Szabo K, Janossy J, Ioja E, Vereczkey L, Krajcsi P: ABCC2/Abcc2: a multispecific transporter with dominant excretory functions. Drug Metab Rev 2010; 42: 402-436.
36. Terlouw SA, Masereeuw R, Russel FG, Miller DS: Nephrotoxicants induce endothelin release and signaling in renal proximal tubules: effect on drug efflux. Mol Pharmacol 2001; 59: 1433-1440.
37. Benigni A, Bruzzi I, Mister M, Azzollini N, Gaspari F, Perico N, Gotti E, Bertani T, Remuzzi G: Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Kidney Int 1999; 55: 674-685.